删除Tmem263会破坏GH/IGF-1轴,导致矮化,并损害骨收购
Dylan C Sarver1, Jean Garcia-Diaz2,3,4, Muzna Saqib1
1Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, United States.
eLife
|January 19, 2024
概括
TMEM263基因对于产后生长至关重要,它调节生长激素 (GH) /胰岛素类生长因子1 (IGF-1) 轴. 它的缺失会导致矮化和骨发育受损,因为它会破坏GH信号传递.
科学领域:
- 遗传学 是一个遗传学.
- 内分泌学 在内分泌学.
- 骨生物学 骨生物学
背景情况:
- 全基因组关联研究 (GWAS) 确定TMEM263作为骨矿物质密度和生长的候选基因.
- TMEM263的突变与各种物种的矮化和骨发育不良有关,但其在产后生长中的因果作用尚不清楚.
研究的目的:
- 研究TMEM263在产后骨生长中的功能,并确定其潜在的分子机制.
主要方法:
- 使用淘汰赛小鼠模型 (Tmem263-null) 研究TMEM263缺失对生长和骨发育的影响.
- 分析了体重,骨矿物质密度,生长板长度和循环IGF-1水平.
- 评估肝脏GH受体 (GHR) 表达和GH诱导的JAK2 / STAT5信号通路.
- 对肝脏组织进行了转录组分析.
主要成果:
- Tmem263-null小鼠表现出严重的产后生长不良,比例矮体和骨收购受损.
- 在出生后的第21天,生长缺陷显而易见,与受损的生长激素 (GH) /胰岛素类生长因子1 (IGF-1) 轴相关.
- 鼠标显示循环IGF-1的低水平,骨质减少,生长板较短,肝脏GHR表达和GH信号减少.
- 肝转录组分析显示,在Tmem263-null男性中,GH调节的基因表达和女性化发生了改变.
结论:
- TMEM263通过维持GH/IGF-1信号通路,在调节产后生长方面发挥着关键的因果作用.
- TMEM263中的缺陷可能导致生长激素不敏感和线性生长受损,这表明对人类骨疾病的潜在影响.
相关概念视频
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Genomic Imprinting and Inheritance
34.5K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
34.5K
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K


